Data / Drug companies / Wal-Mart Stores Inc
Wal-Mart Stores Inc: 357 products in the FDA NDC directory, labeler code 49035
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Wal-Mart Stores Inc (labeler code 49035) lists 357 products in the FDA National Drug Code Directory, covering 157 finished drugs by generic name. By type: 357 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on April 20, 2026.
The request: Watch Wal-Mart Stores Inc (FDA labeler code 49035): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 49035
- Products in commercial distribution
- 357
- Packages
- 545
- Finished drugs by generic name
- 157
- Prescription products
- 0
- Over the counter products
- 357
- Flagged as original packager
- 324 of 324 products that carry the flag
- Started marketing in the last 12 months
- 1
- Products with a marketing end date set
- 20
- Earliest marketing start
- May 24, 1988
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 238 | 66.7% |
| Generic drugs (ANDA) | 101 | 28.3% |
| New drug applications (NDA) | 7 | 2% |
| Unapproved homeopathic products | 4 | 1.1% |
| Other unapproved drugs | 4 | 1.1% |
| Authorized generics (NDA) | 3 | 0.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 357 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 27 | 7.6% |
| Tablet, chewable | 27 | 7.6% |
| Tablet, film coated | 27 | 7.6% |
| Solution | 22 | 6.2% |
| Cream | 21 | 5.9% |
| Suspension | 18 | 5% |
| Tablet | 17 | 4.8% |
| Lozenge | 15 | 4.2% |
| Kit | 14 | 3.9% |
| Capsule, liquid filled | 14 | 3.9% |
| Gel | 12 | 3.4% |
| Gum, chewing | 12 | 3.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Gum Detoxify | 49035-174 | Paste, dentifrice | Over the counter monograph drugs | April 20, 2026 |
| Budesonide | 49035-703 | Spray, metered | Generic drugs (ANDA) | July 1, 2025 |
| Daytime Nighttime Childrens Multi-symptom Cold | 49035-938 | Kit | Over the counter monograph drugs | November 26, 2024 |
| Equate Mucus Relief | 49035-284 | Tablet, extended release | Generic drugs (ANDA) | April 9, 2024 |
| Equate hair regrowth treatment | 49035-746 | Solution | Generic drugs (ANDA) | September 14, 2021 |
| Diclofenac sodium | 49035-269 | Gel | Generic drugs (ANDA) | May 3, 2021 |
| Chocolate Laxative Regular strength, Sennosides Stimulant Laxative, equate | 49035-349 | Tablet, chewable | Over the counter monograph drugs | February 23, 2021 |
| Stool Softener Laxative | 49035-526 | Capsule, liquid filled | Over the counter monograph drugs | January 31, 2021 |
| Nicotine Mini | 49035-493 | Lozenge | Generic drugs (ANDA) | January 15, 2021 |
| Mini Nicotine | 49035-436 | Lozenge | Generic drugs (ANDA) | January 15, 2021 |
| Walmart | 49035-814 | Swab | Over the counter monograph drugs | January 1, 2021 |
| Maximum Strength Non Drowsy Day and Night Cold and Flu | 49035-674 | Kit | Over the counter monograph drugs | November 16, 2020 |
| Day and Night Sinus | 49035-356 | Kit | Over the counter monograph drugs | October 23, 2020 |
| Equate diarrhea control | 49035-695 | Suspension | Generic drugs (ANDA) | September 3, 2020 |
| Medicated Body Extra Strength Powder | 49035-822 | Powder | Over the counter monograph drugs | September 1, 2020 |
| Maximum Strength Medicated Foot Powder | 49035-795 | Powder | Over the counter monograph drugs | September 1, 2020 |
| Stool Softener Laxative | 49035-385 | Capsule, liquid filled | Over the counter monograph drugs | September 1, 2020 |
| Laxative and Stool Softener | 49035-360 | Tablet | Over the counter monograph drugs | September 1, 2020 |
| Sool Softener Laxative | 49035-270 | Tablet | Over the counter monograph drugs | September 1, 2020 |
| Equate arthritis pain | 49035-262 | Gel | Generic drugs (ANDA) | August 17, 2020 |
| Equate allergy and congestion relief | 49035-643 | Tablet, film coated, extended release | Generic drugs (ANDA) | July 24, 2020 |
| Equate vapor ice cold and flu | 49035-813 | Tablet, film coated | Over the counter monograph drugs | July 16, 2020 |
| Sinus and Congestion Non-Drowsy | 49035-780 | Tablet, film coated | Over the counter monograph drugs | July 15, 2020 |
| Equate daytime severe vaporice cold and flu nighttime severe vapor ice cold and flu | 49035-796 | Kit | Over the counter monograph drugs | July 14, 2020 |
| Equate vapor ice cold and flu | 49035-708 | Tablet, film coated | Over the counter monograph drugs | July 14, 2020 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.